RNA Interference Technology Will Improve Pharmaceutical Production

RNA interference, or RNAi, has become a novel and useful tool for silencing gene expression in both cells and organisms as well as in developing therapies for diseases. A new study out of Taiwan has recently been published outlining how RNAi technology can be used to vastly increase the quantity and quality of recombinant protein production in Chinese hamster ovary (CHO) cells, the key mammalian cell line for biological pharmaceutical production. This may mean faster development of medications, therapies, and vaccines, as well as lower costs for treatment.

Read the full publication at PubMed (Biotechnology Advances): RNA interference technology to improve recombinant protein production in Chinese hamster ovary cells

Related posts:

1. Baylor researchers find fat cell blocker
2. More Proof That Smoking Leads to Small-Cell Lung Cancer
3. Genetic Cause For Type Of Deafness Identified; Discovery Could Lead To New Therapies For Progressive Hearing Loss
4. First Genetic Link Between Reptile And Human Heart Evolution Found
5. Visualize the Unbelievably Small Scale of the Cell (and other Biological Structures)